ArticleTrials2022

Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary care.

Sarah L Alderson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.